Samsara BioCapital’s HOOKIPA Pharma HOOK Stock Holding History

Samsara BioCapital’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,966	Closed	-$1.44M	–	48
2020 Q4	$1.44M	Buy	12,966 +1,306	+11%	+$141K	0.14%	36
2020 Q3	$1.1M	Sell	11,660 -28,365	-71%	-$2.89M	0.31%	32
2020 Q2	$4.65M	Sell	40,025 -13,000	-25%	-$1.27M	1.5%	18
2020 Q1	$4.38M	Hold	53,025	–	–	2.52%	10
2019 Q4	$6.49M	Hold	53,025	–	–	3.11%	10
2019 Q3	$3.98M	Hold	53,025	–	–	2.71%	10
2019 Q2	$3.57M	Buy	+53,025	New	+$5.62M	2.36%	10

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Samsara BioCapital's HOOK Position: Q1 2021 in Review

Samsara BioCapital sold out of HOOKIPA Pharma (HOOK) in Q1 2021, closing a stake of 12,966 shares — an estimated $1.44M sold.

Samsara BioCapital first reported a position in HOOK in Q2 2019 and held it in 7 quarters. The position peaked at $6.49M in Q4 2019. 62 funds tracked by Wall St. Rank hold HOOK as of Q1 2021.

Samsara BioCapital reported no remaining HOOKIPA Pharma position as of Q1 2021 after selling out during the quarter.
Samsara BioCapital sold 12,966 HOOKIPA Pharma shares in Q1 2021, an estimated $1.44M.
Samsara BioCapital first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 7 quarters.
Samsara BioCapital's HOOKIPA Pharma position peaked at $6.49M in Q4 2019.
62 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2021.

Based on Samsara BioCapital's 13F filing for Q1 2021, filed 18 May 2021.